The prevention and management of alloimmunization in sickle cell disease: the benefit of extended phenotypic matching of red blood cells.
Immunohematology., 28(1):20-3 (2012)
Deferoxamine treatment during pregnancy: is it harmful?
Am. J. Hematol., Jan;60(1):24-6 (1999)
Sample suitability for the detection of minor white cell populations (microchimerism) by polymerase chain reaction.
Transfusion., 38(11-12):1041-5 (1998 Nov-Dec)
Outreach strategies for Asian Pacific Island (API) communities.
Ann. N. Y. Acad. Sci., Jun;850:514-5 (1998)
Approaches to working with adult thalassemia patients in pediatric settings.
Ann. N. Y. Acad. Sci., Jun;850:516-7 (1998)
The social impact of migration on disease. Cooley's anemia, thalassemia, and new Asian immigrants.
Ann. N. Y. Acad. Sci., Jun;850:509-11 (1998)
Preliminary report: hydroxyurea produces significant clinical response in thalassemia intermedia.
Ann. N. Y. Acad. Sci., Jun;850:461-2 (1998)
The morbidity of bone disease in thalassemia.
Ann. N. Y. Acad. Sci., Jun;850:344-8 (1998)
The hemoglobin E syndromes.
Ann. N. Y. Acad. Sci., Jun;850:334-43 (1998)
Correction of the anemia of epidermolysis bullosa with intravenous iron and erythropoietin.
J. Pediatr., May;132(5):871-3 (1998)
Hydroxyurea in children: present and future.
Semin. Hematol., Jul;34(3 Suppl 3):22-9 (1997)
New therapies and approaches to transfusion in sickle cell disease in children.
Curr. Opin. Pediatr., Feb;9(1):41-5 (1997)
Core decompression in avascular necrosis of the hip in sickle-cell disease.
Am. J. Hematol., Jun;52(2):103-7 (1996)
Phospholipase A2 levels in acute chest syndrome of sickle cell disease.
Blood., Mar;87(6):2573-8 (1996)
Ototoxicity in hemoglobinopathy patients chelated with desferrioxamine.
J. Pediatr. Hematol. Oncol., Feb;18(1):42-5 (1996)
A comparison of conservative and aggressive transfusion regimens in the perioperative management of sickle cell disease. The Preoperative Transfusion in Sickle Cell Disease Study Group.
N. Engl. J. Med., Jul;333(4):206-13 (1995)
A cautionary note regarding hydroxyurea in sickle cell disease.
Blood., Feb;83(4):1124-8 (1994)
Comprehensive care in sickle cell disease: its impact on morbidity and mortality.
Semin. Hematol., Jul;28(3):220-6 (1991)
Alloimmunization in sickle cell anemia and transfusion of racially unmatched blood.
N. Engl. J. Med., Jun;322(23):1617-21 (1990)
Sickle cell anemia and related hemoglobinopathies.
Pediatr. Clin. North Am., May;27(2):429-47 (1980)